Roger I. Glass, MD, PhD became President of CMB on April 15, 2023. He brings to this role four decades of experience in global health, including leadership roles in public service, research, capacity building, and international collaboration.
Dr. Glass graduated from Harvard College in 1967, received a Fulbright Fellowship to study at the University of Buenos Aires in 1967, and received his MD from Harvard Medical School and his MPH from the Harvard School of Public Health in 1972. He received his PhD in Medical Microbiology from the University of Goteborg, Sweden in 1984. Dr. Glass spent much of his career at the U.S. Centers for Disease and Prevention (CDC), starting as a medical officer assigned to the Environmental Hazards Branch in 1977. On secondment from CDC, he worked as a Scientist at the International Center for Diarrheal Disease Research, Bangladesh from 1979-1983. In 1984, he joined the National Institutes of Health Laboratory of Infectious Diseases, where he worked on the molecular biology of rotavirus. In 1986, Dr. Glass returned to the CDC to become Chief of the Viral Gastroenteritis Unit at the National Center for Infectious Diseases.
Most recently, Dr. Glass served as the longest-serving Director of the Fogarty International Center (2006-2023) and as the Associate Director for International Research at the U.S. National Institutes of Health (NIH). At the Fogarty International Center, he led efforts to support and facilitate global health research conducted by U.S. and international investigators, building partnerships between health research institutions in the United States and abroad, and training the next generation of scientists to address global health needs.
Dr. Glass's research interests include the prevention of gastroenteritis from rotaviruses and other agents through the application of novel scientific research. He has maintained field studies in India, Bangladesh, Brazil, Mexico, Israel, Russia, Vietnam, China and elsewhere. His research has been targeted toward epidemiologic studies to anticipate the introduction of rotavirus vaccines. He has co-authored more than 600 research papers and chapters.
